Tags Archive Navigation
icon
-
Featured NewsWorld Sight Day 2022: Raising awareness on the importance of eye health
-
Media ReleaseNovartis announces European Commission approval of Beovu® for people living with diabetic macular edema
-
Featured NewsWorld Sight Day 2021
-
StoryRestoring vision and hope to thousands in Southeast Asia
-
Media ReleaseNovartis acquires Vedere Bio, adding novel optogenetic gene therapy technology for treating blindness
-
Media ReleaseUS FDA approves updated Novartis Beovu® label, to include additional safety information
-
Media ReleaseNew Novartis analysis shows wet AMD patients achieved sustained fluid control faster with Beovu® versus aflibercept
-
StoryVisionary: Silke Mader has a vision for the care of premature infants and their parents
-
StoryLessons from a blind chef
-
StoryCoping with eye disease and fading vision late in life
-
StoryWhat goes wrong with the window to the soul in glaucoma?
-
StoryOpening chemistry education to the world